SEC Form 4 · accession 0001209191-16-128401
IMMUNE DESIGN CORP. · IMDZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Susan L. Kelley
Director
Period of report
Jun 15, 2016
Accepted (ET)
Jun 17, 2016 · 1:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001437786
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $10.10 | Jun 15, 2016 | A | 23,300 | A | — | Jun 15, 2026 | Common Stock | 23,300 | 23,300 | D |
Explanation of responses
- F1One third of the option shares will vest on June 15, 2017 and the remaining balance of the option shares will vest in a series of 24 equal consecutive monthly installments thereafter until fully vested.